Navigation Links
Gene therapy reverses genetic mutation responsible for heart failure in muscular dystrophy

that the treatment would be effective. However, we never imagined it would be so effective, particularly in protecting against or reversing the damage to the heart caused by this mutation and extending lifespan," explained Dr. Tong Zhu, M.D., Ph.D., a research associate in the department of orthopaedic surgery and the first author of the study. "In fact, if this study holds up in human clinical trials, it may have profound implications for the treatment of heart failure."

Dr. Xiao cautioned, however, that human clinical trials of this therapy face several major challenges. Foremost is that effective treatment requires the injection of a large amount of the virus so there is enough to reach every muscle cell. Because 30 percent to 40 percent of the population has antibodies to human AAVs, there is always the possibility that the effectiveness of this form of gene therapy may be blunted by a host immune response. However, Dr. Xiao is optimistic that will not be the case.

"The AAV-8 we used in this study was isolated from monkeys, so we are very hopeful it will be able to deliver the genes before the human immune system produces antibodies to block it. In addition, we used a muscle-specific promoter in the virus, which also should lower the risk of any potential immune response against the gene product. In fact, in hamsters, we did not find any immune response to the human delta-sarcoglycan protein that was encoded by the AAV vector under the control of this promoter," he explained.

In addition to Drs. Xiao and Zhu, other authors of this study are: Liqiao Zhou, V.M.D.; Zhong Wang, M.D., Ph.D.; Chunping Qiao, M.D., Ph.D.; Chunlian Chen, M.D.; and Juan Li, M.D., Molecular Therapy Laboratory, department of orthopaedic surgery, and Satsuki Mori, M.D., and Charles McTiernan, Ph.D., Cardiovascular Institute, all from the University of Pittsburgh School of Medicine; and Daowen Wang, M.D., Ph.D., department of cardiology, Tongi Hospital, Huazhong Scie
'"/>

Source:University of Pittsburgh Medical Center


Page: 1 2 3 4

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors
Post Your Comments:
(Date:8/27/2014)... available in German . ... most common inherited disease affecting the peripheral nervous system. ... Planck Institute of Experimental Medicine and University Medical Centre ... is impaired in rats with the disease. These cells ... as myelin, which facilitates the rapid transfer of electrical ...
(Date:8/27/2014)... that a deficiency in serotonin a chemical messenger ... depression. In the journal ACS Chemical Neuroscience , ... serotonin in their brains (and thus should have been ... , Donald Kuhn and colleagues at the John ... School of Medicine note that depression poses a major ...
(Date:8/27/2014)... advocates, campaigns against trans-fats have largely succeeded in ... aim at sugar for its potential contributions to ... still wrangling over the best way to assuage ... article in Chemical & Engineering News ... Chemical Society. , In the article, Stephen Ritter, ...
Breaking Biology News(10 mins):Potential therapy for incurable Charcot-Marie-Tooth disease 2New study throws into question long-held belief about depression 2
... female hormone estrogen is known to offer protection for the heart, ... New research from the University of California at Merced finds that ... a greater impact on girls, blood pressure than it does on ... between 13 and 17 years old, obese boys were 3.5 times ...
... reached epidemic levels, and pediatricians are on the front ... pre-conference session at 11:30 a.m. Friday, Oct. 14, before ... Exhibition in Boston. The Pediatrics for the ... Innovations in Practice," challenges pediatricians to "step it up ...
... Oct. 11, 2011 Based on its recent analysis ... with the 2011 North American Frost & Sullivan Award ... Biometric Platform™ , - the first scalable, multi-modal biometrics ... iris recognition from a single server. To ...
Cached Biology News:Gender differences in blood pressure appears as early as adolescence 2Pediatricians aim to end childhood obesity within a generation 2Frost & Sullivan Recognizes M2SYS for its Path-Breaking Hybrid Biometric Platform(TM) That Offers Unparalleled Flexibility to End-Users 2Frost & Sullivan Recognizes M2SYS for its Path-Breaking Hybrid Biometric Platform(TM) That Offers Unparalleled Flexibility to End-Users 3Frost & Sullivan Recognizes M2SYS for its Path-Breaking Hybrid Biometric Platform(TM) That Offers Unparalleled Flexibility to End-Users 4
(Date:8/27/2014)... survive impact by the huge amounts of energy ... energy for photosynthesis. The hypothesis is that the ... the energy throughout the entire protein molecule through ... now managed to successfully ,film, this process. , ... which play a role in photosynthesis and thus ...
(Date:8/27/2014)... 27, 2014 Research and Markets ... Lactic Acid  (Biodegradable Polymer, Food & Beverage, Personal ... to 2019" report to their offering. ... with an asymmetrical carbon atom. The main applications ... food and beverage, personal care product, and pharmaceutical ...
(Date:8/27/2014)... 2014 “We are honored to be ... Ven Thangaraj, CEO of Radiant Sage. “We are offering ... the imaging corelab market to a different level. ... organizations to efficiently and effectively manage the massive amounts ... be analyzed and read by trained physicians. Being recognized ...
(Date:8/27/2014)... 2014 Flagship Biosciences LLC, a leading ... the pharmaceutical and medical device industries, has announced a ... growing company has consolidated its histology and tissue analysis ... Westminster, CO, just north of Denver. The new ... 103rd Ave., Suite 100, Westminster, CO 80021 , Tissue ...
Breaking Biology Technology:DTU researchers film protein quake for the first time 2Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2Flagship Biosciences Announces Relocation and Expansion 2
... (Nasdaq: NPSP ) today reported its financial results ... update on its 2007 milestones and,financial guidance. Update ... partnership with Nycomed to develop,GATTEX(TM) (teduglutide) outside North America, ... corporate milestones for 2007. The company announced that it,has: ...
... Merge Healthcare (Nasdaq: MRGE ; TSX: MRG), today,announced ... NASDAQ,Listing Qualifications Panel stating that the panel determined to ... NASDAQ Stock Market,subject to the Company,s filing of its ... no later than January 29, 2008. As indicated in ...
... Mass., Nov. 1 Proteon Therapeutics,( http://www.proteontherapeutics.com ... first-in-class pharmaceuticals to address the,medical needs of ... presenting,tomorrow at the Annual Meeting of the ... Human Elastase (PRT-201) Dilates Outflow,Veins in a ...
Cached Biology Technology:NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 2NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 3NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 4NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 5NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 6NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 7NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 8NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 9NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance 2NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance 3Proteon Therapeutics to Present at Annual Meeting of American Society of Nephrology in San Francisco on November 2, 2007 2
... Software enables you to identify over ... can distinguish protein isoforms, protein subsets, ... also visualize peptide-protein associations and relationships ... protein identification and relative protein expression ...
... microscopes offer all of the features of ... Equipped with Koehler illumination, a centerable condenser ... B3 is the workhorse of Motic's range ... the need for re-focusing following a change ...
... Green II RNA gel stain is ... has bright fluorescence when bound to RNA ... ideal for use with either formaldehyde/agarose or ... UV transilluminators. A 500 µL unit size ...
... SYBR Green II RNA gel stain is ... bright fluorescence when bound to RNA and low ... with either formaldehyde/agarose or polyacrylamide gels using laser ... 100 minigels. A 500 µL unit size (S-7564) ...
Biology Products: